NSC |
Compound |
Enrichment |
Correlation |
NSC 694619 |
Null |
0.0352028253287042 |
-0.24627722 |
NSC 718564 |
Null |
0.0352028253287042 |
-0.064632452 |
NSC 718781 |
Erlotinib hydrochloride |
0.0352028253287042 |
0.20353516 |
NSC 719667 |
7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one |
0.0352028253287042 |
-0.10955232 |
NSC 725098 |
Null |
0.0352028253287042 |
-0.30266156 |
NSC 726089 |
11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate |
0.0352028253287042 |
-0.32357791 |
NSC 731704 |
1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. |
0.0352028253287042 |
-0.21374377 |
NSC 732936 |
5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.0352028253287042 |
-0.19450381 |
NSC 732962 |
5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone |
0.0352028253287042 |
-0.39210481 |
NSC 741425 |
3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide |
0.0352028253287042 |
-0.13168201 |